Beilstein J. Org. Chem. 2015, 11, 184–191.
phorus inversion. The high barrier is consistent with the absence Acknowledgements
of acylphosphonite epimerization of 12 and 13, and this Mass spectra were obtained at the North Carolina State Univer-
suggests that any amide-like stabilization of the phosphorus sity Mass Spectrometry Facility located in the Department of
lone pair in a trigonal transition state is eliminated by Chemistry. Financial support from the City University of New
oxygen–phosphorus lone pair–lone pair repulsion.
York PSC-CUNY Research Award Program is gratefully
acknowledged.
Conclusion
References
High-yield syntheses have been developed for some novel phos-
phorus synthons, including the acyl and benzoyldiamidites via
the surprising condensation of phosphonodiamidite 4 and the
two acid chlorides with elimination of HCl. The nucleoside
acylphosphonamidites were also readily prepared, although the
benzoyl analog 11 was more easily isolated (albeit as the
diastereomeric mixture of P-epimers), while the acetyl analog
10 allowed the diastereomers to be separated following repeated
chromatographies. Final coupling to give the dinucleoside
acylphosphonites proceeded smoothly, but separation of the
pure compounds from the nucleoside precursors could not be
completely achieved. If the pure acylphosphonites are to be
obtained, solid-phase synthesis would probably be required.
The chromatography results suggested that room-temperature
epimerization at phosphorus did not occur, and heating at
50–150 °C also gave no indication of epimerization. Density
functional theory calculations are consistent with this result,
giving a calculated inversion barrier of 42 kcal/mol. While one
might argue that given the results of such a calculation, the lack
of epimerization was a foregone conclusion, it is still important
to test theory with experiment. In conclusion, the analogy
between phosphines and phosphites, in which the low barrier to
acylphosphine inversion suggested that the same might occur
with acylphosphonites, is in this case superficial, and the antici-
pated low-temperature inversion does not occur.
1. Matsukura, M.; Shinozuka, K.; Zon, G.; Mitsuya, H.; Reitz, M.;
Cohen, J. S.; Broder, S. Proc. Natl. Acad. Sci. U. S. A. 1987, 84,
2. Uhlmann, E.; Peyman, A. Chem. Rev. 1990, 90, 543–584.
3. Crooke, S. T.; Geary, R. S. Br. J. Clin. Pharmacol. 2013, 76, 269–276.
4. Lee, J. J. A.; Yokota, T. J. Pers. Med. 2013, 3, 144–176.
5. Šípová, H.; Špringer, T.; Rejman, D.; Šimák, O.; Petrová, M.;
Novák, P.; Rosenbergová, S.; Páv, O.; Liboska, R.; Barvík, I.;
Štěpánek, J.; Rosenberg, I.; Homola, J. Nucleic Acids Res. 2014, 42,
6. Prakash, T. P.; Graham, M. J.; Yu, J.; Carty, R.; Low, A.; Chappell, A.;
Schmidt, K.; Zhao, C.; Aghajan, M.; Murray, H. F.; Riney, S.;
Booten, S. L.; Murray, S. F.; Gaus, H.; Crosby, J.; Lima, W. F.; Guo, S.;
Monia, B. P.; Swayze, E. E.; Seth, P. P. Nucleic Acids Res. 2014, 42,
7. Magen, I.; Hornstein, E. Brain Res. 2014, 1584, 116–128.
8. Marwick, C. JAMA 1998, 280, 871.
10.Marshall, W. S.; Caruthers, M. H. Science 1993, 259, 1564–1570.
11.Li, P.; Sergueeva, Z. A.; Dobrikov, M.; Shaw, B. R. Chem. Rev. 2007,
12.Uehara, S.; Hiura, S.; Higashida, R.; Oka, N.; Wada, T. J. Org. Chem.
13.Stec, W. J.; Grajkowski, A.; Kobylanska, A.; Karwowski, B.;
Koziolkiewicz, M.; Misiura, K.; Okruszek, A.; Wilk, A.; Guga, P.;
Boczkowska, M. J. Am. Chem. Soc. 1995, 117, 12019–12029.
Supporting Information
Supporting Information contains the experimental
procedures, characterization of new compounds, copies of
1H, 13C and 31P NMR spectra, IR spectra, details of the
X-ray structure determination, and details of the DFT
calculations.
14.Stec, W. J.; Karwowski, B.; Boczkowska, M.; Guga, P.;
Koziołkiewicz, M.; Sochacki, M.; Wieczorek, M. W.; Blaszczyk, J.
15.Wang, J.-C.; Just, G. J. Org. Chem. 1999, 64, 8090–8097.
16.Wilk, A.; Grajkowski, A.; Phillips, L. R.; Beaucage, S. L.
17.Yu, D.; Kandimalla, E. R.; Roskey, A.; Zhao, Q.; Chen, L.; Chen, J.;
Agrawal, S. Bioorg. Med. Chem. 2000, 8, 275–284.
Supporting Information File 1
Experimental.
18.Almer, H.; Szabo, T.; Stawinski, J. Chem. Commun. 2004, 290–291.
Supporting Information File 2
CIF file of compound 9.
19.Oka, N.; Yamamoto, M.; Sato, T.; Wada, T. J. Am. Chem. Soc. 2008,
20.Lu, Y. Mini-Rev. Med. Chem. 2006, 6, 319–330.
190